{
    "cancelStatus": "1",
    "cancelDate": "2018-12-27",
    "cancelReason": [
        "841"
    ],
    "licid": "02025765",
    "validDate": "2022-07-20 00:00:00.000",
    "issueDate": "2012-07-20 00:00:00.000",
    "licKind": "02",
    "oldLicid": null,
    "certNo": "DHA00202576508",
    "prodNameC": "怡瑞納\"山德士\"20毫克\/毫升注射液",
    "prodNameE": "Irinotecan Sandoz 20mg\/ml concentrate for solution for infusion",
    "indicationsName": [
        "晚期性大腸直腸癌之第一線治療藥物：與5-FU及folinic acid合併，使用於未曾接受過化學治療之患者。單獨使用於曾接受5-FU療程治療無效之患者。與cetuximab併用，治療曾接受含irinotecan之細胞毒性療法治療失敗且具有上皮生長因子接受體(EGFR)表現型KRAS野生型轉移性大腸直腸癌患者。與5-fluorouracol、folinic acid及bevacizumab合併治療，作為轉移性大腸癌或直腸癌患者的第一線治療藥物。與capecitabine合併治療，作為轉移性大腸直腸癌患者的第一線治療藥物。"
    ],
    "does": "2270",
    "packageUnit": [
        {
            "packageSpec": "2、5、7.5、15、25毫升",
            "packageUnit": "L2"
        },
        {
            "packageSpec": "100支以下",
            "packageUnit": "03"
        }
    ],
    "medMCode": "05",
    "maMedCode": null,
    "medDCode": null,
    "ingredientsDesc": [
        "IRINOTECAN HYDROCHLORIDE TRIHYDRATE"
    ],
    "restraintItemsCode": [
        "02",
        "1Q",
        "24"
    ],
    "applicantName": "台灣諾華股份有限公司",
    "applicantAddr": "台北市中正區仁愛路二段99號11、12、13樓",
    "medClass": null,
    "efficacy": " ",
    "mdFormat": null,
    "productAnnotation": null,
    "mdKind": [],
    "monitorDate": null,
    "licidNew": null,
    "licidOld": null,
    "factoryDtoList": [
        {
            "factoryCode": "1",
            "factoryName": "EBEWE PHARMA GES.M.B.H.NFG. KG",
            "factoryAddr": "MONDSEESTRABE 11,AT-4866 UNTERACH AM ATTERSEE, AUSTRIA",
            "factoryCompanyAddr": null,
            "countryCode": "AT",
            "processCode": [],
            "processCodeStr": null,
            "factoryKind": "M",
            "factoryNo": "FAT0024000",
            "factoryInfo": null,
            "qsd": null
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": "9200037710",
            "ingredientsDesc": "IRINOTECAN HYDROCHLORIDE TRIHYDRATE",
            "concentDesc": "(corr. To 18.4mg irinotecan hydrochlorid",
            "concent": "20.000",
            "concentUnit": "001",
            "seq": "1",
            "prescription_seq": "1",
            "prescription_Kind": "1"
        }
    ],
    "authDtoList": [],
    "iomDtoList": [],
    "changeDtoList": [],
    "atcList": [
        {
            "isMain": "1",
            "atcCode": "L01CE02"
        }
    ]
}